Pfenex: Update; Still A Buy For Their Therapeutic Proteins Platform [Seeking Alpha]
PFENEX INC (PFNX)
NASDAQ:AMEX Investor Relations:
pfenex.com
Company Research
Source: Seeking Alpha
Summary PFNX has made much progress since my first article in May 2018, including the approval of their first bio-similar osteoporosis drug, PF 708 on Oct 7, 2019. PFNX has an advanced pipeline, and significant partnership/license agreements for various therapeutic proteins from their proprietary platform. According to PFNX, the value drivers include up to $221M in upfronts and potential milestone still eligible to receive, and multiple other potential near-term milestones and sales royalties. PFNX remains a BUY for their therapeutic proteins platform, as the company continues to advance their pipeline and execute their business plan successfully. The company Pfenex The company has made great progress since my first article, entitled ' Pfenex: A Buy for Their Therapeutic Proteins Platform Here are some examples (the list is not complete) since that time: Date Headline 2018/06/11 Pfenex and Alvogen Enter into U.S. Agreement for Commercialization of PF708, a Therapeutic Equivalent Candi
Show less
Read more
Impact Snapshot
Event Time:
PFNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFNX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFNX alerts
High impacting PFENEX INC news events
Weekly update
A roundup of the hottest topics